<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cohen S</submitter><funding>NIDA NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>72-85</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3226708</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>72(1)</volume><pubmed_abstract>Autism spectrum disorders such as Rett syndrome (RTT) have been hypothesized to arise from defects in experience-dependent synapse maturation. RTT is caused by mutations in MECP2, a nuclear protein that becomes phosphorylated at S421 in response to neuronal activation. We show here that disruption of MeCP2 S421 phosphorylation in vivo results in defects in synapse development and behavior, implicating activity-dependent regulation of MeCP2 in brain development and RTT. We investigated the mechanism by which S421 phosphorylation regulates MeCP2 function and show by chromatin immunoprecipitation-sequencing that this modification occurs on MeCP2 bound across the genome. The phosphorylation of MeCP2 S421 appears not to regulate the expression of specific genes; rather, MeCP2 functions as a histone-like factor whose phosphorylation may facilitate a genome-wide response of chromatin to neuronal activity during nervous system development. We propose that RTT results in part from a loss of this experience-dependent chromatin remodeling.</pubmed_abstract><journal>Neuron</journal><pubmed_title>Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function.</pubmed_title><pmcid>PMC3226708</pmcid><funding_grant_id>R01 NS048276-08</funding_grant_id><funding_grant_id>R00 NS058391</funding_grant_id><funding_grant_id>R01 NS048276-06</funding_grant_id><funding_grant_id>R01 NS048276-07</funding_grant_id><funding_grant_id>R01 DA022202</funding_grant_id><funding_grant_id>R01 NS048276-04</funding_grant_id><funding_grant_id>1R01NS048276</funding_grant_id><funding_grant_id>K08MH90306</funding_grant_id><funding_grant_id>R01 NS048276-05</funding_grant_id><funding_grant_id>R01 NS048276-02</funding_grant_id><funding_grant_id>R01 NS048276-03</funding_grant_id><funding_grant_id>T32 GM007753</funding_grant_id><funding_grant_id>R01 NS048276</funding_grant_id><funding_grant_id>T32 CA009361</funding_grant_id><funding_grant_id>R21 NS070250</funding_grant_id><funding_grant_id>R01 NS048276-06S1</funding_grant_id><funding_grant_id>DP2 OD006461</funding_grant_id><funding_grant_id>K08 MH090306</funding_grant_id><funding_grant_id>T32CA009361</funding_grant_id><funding_grant_id>R01 NS048276-01</funding_grant_id><funding_grant_id>1R21NS070250-01A1</funding_grant_id><funding_grant_id>K99 NS058391</funding_grant_id><pubmed_authors>Sadacca LA</pubmed_authors><pubmed_authors>Hemberg M</pubmed_authors><pubmed_authors>Gabel HW</pubmed_authors><pubmed_authors>Cohen S</pubmed_authors><pubmed_authors>Greenberg RS</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>Wetsel WC</pubmed_authors><pubmed_authors>Ebert DH</pubmed_authors><pubmed_authors>West AE</pubmed_authors><pubmed_authors>Greenberg ME</pubmed_authors><pubmed_authors>Harmin DA</pubmed_authors><pubmed_authors>Hutchinson AN</pubmed_authors><pubmed_authors>Verdine VK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function.</name><description>Autism spectrum disorders such as Rett syndrome (RTT) have been hypothesized to arise from defects in experience-dependent synapse maturation. RTT is caused by mutations in MECP2, a nuclear protein that becomes phosphorylated at S421 in response to neuronal activation. We show here that disruption of MeCP2 S421 phosphorylation in vivo results in defects in synapse development and behavior, implicating activity-dependent regulation of MeCP2 in brain development and RTT. We investigated the mechanism by which S421 phosphorylation regulates MeCP2 function and show by chromatin immunoprecipitation-sequencing that this modification occurs on MeCP2 bound across the genome. The phosphorylation of MeCP2 S421 appears not to regulate the expression of specific genes; rather, MeCP2 functions as a histone-like factor whose phosphorylation may facilitate a genome-wide response of chromatin to neuronal activity during nervous system development. We propose that RTT results in part from a loss of this experience-dependent chromatin remodeling.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Oct</publication><modification>2020-10-29T13:21:41Z</modification><creation>2019-03-27T00:46:32Z</creation></dates><accession>S-EPMC3226708</accession><cross_references><pubmed>21982370</pubmed><doi>10.1016/j.neuron.2011.08.022</doi></cross_references></HashMap>